Altos Labs is a biotechnology company focused on cellular rejuvenation — understanding how cells lose their health and resilience and developing ways to restore those properties. Its broader mission is to use this science to reverse disease, injury and disabilities that can occur throughout life.

The company combines the scientific freedom and curiosity of academia with the translational focus of the pharmaceutical industry. Its researchers investigate the fundamental biology of cell health, including cellular reprogramming and rejuvenation, with the aim of developing medicines that can restore the function of damaged or ageing cells while preserving their identity. This work builds on discoveries showing that mature cells can be partially reprogrammed towards younger, more resilient states without completely reverting them to stem cells.

Altos also places significant emphasis on computational biology and machine learning. Its Institute of Computation is developing multi-scale models intended to better understand the relationships between cell health, tissue and organ function, while helping researchers discover and design potential rejuvenation and reprogramming interventions.

With operations in the San Francisco Bay Area, San Diego and Cambridge, UK, Altos brings together scientists, clinicians and industry leaders from around the world. The company says its ultimate goal is to translate advances in cellular rejuvenation into transformative medicines that could help people live healthier lives and remain free from disease and disability for longer.